Loading clinical trials...
Loading clinical trials...
Following the 6th Tromso study subjects with HbA1c \> 5.7 plus a subsample of subjects with lower hba1c values will be invited to an oral glucose tolerance test to see the predictive value of HBA1c in...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Tromso
NCT07659535 · Type 2 Diabetes
NCT07011147 · Type 1 Diabetes (T1D), Type 2 Diabetes, and more
NCT07581145 · Foot Ulcer Due to Type 2 Diabetes Mellitus
NCT07187830 · Chronic Kidney Disease in Type 2 Diabetes, Obesity & Overweight
NCT07023406 · Type 2 Diabetes Mellitus (T2DM)
University Hospital of North Norway
Tromsø, Tromsø
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions